MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 124 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $87,000 | -56.3% | 1,674 | -72.1% | 0.00% | 0.0% |
Q2 2020 | $199,000 | +1143.8% | 6,010 | +598.0% | 0.00% | – |
Q1 2020 | $16,000 | 0.0% | 861 | 0.0% | 0.00% | – |
Q4 2019 | $16,000 | +77.8% | 861 | +19.4% | 0.00% | – |
Q3 2019 | $9,000 | +125.0% | 721 | +99.2% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 362 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | +25.0% | 362 | -16.8% | 0.00% | – |
Q4 2018 | $4,000 | -50.0% | 435 | -29.6% | 0.00% | – |
Q1 2018 | $8,000 | 0.0% | 618 | 0.0% | 0.00% | – |
Q4 2017 | $8,000 | -97.1% | 618 | -95.9% | 0.00% | -100.0% |
Q3 2017 | $276,000 | -50.6% | 14,958 | -64.3% | 0.00% | -66.7% |
Q2 2017 | $559,000 | 0.0% | 41,879 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $559,000 | +55800.0% | 41,879 | +35092.4% | 0.00% | – |
Q2 2016 | $1,000 | -99.5% | 119 | -99.5% | 0.00% | -100.0% |
Q1 2016 | $216,000 | -37.4% | 23,403 | +0.5% | 0.00% | -50.0% |
Q4 2015 | $345,000 | -9.7% | 23,284 | 0.0% | 0.00% | -33.3% |
Q3 2015 | $382,000 | +1719.0% | 23,284 | +1534.0% | 0.00% | – |
Q2 2013 | $21,000 | -92.0% | 1,425 | -92.8% | 0.00% | -100.0% |
Q1 2013 | $263,000 | -4.7% | 19,760 | +4.1% | 0.02% | -23.3% |
Q3 2012 | $276,000 | – | 18,981 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NORTH TIDE CAPITAL, LLC | 2,500,000 | $28,350,000 | 2.16% |
SENZAR ASSET MANAGEMENT, LLC | 454,600 | $5,155,000 | 1.51% |
Palo Alto Investors LP | 1,455,176 | $16,502,000 | 1.23% |
SECTORAL ASSET MANAGEMENT INC | 2,134,440 | $24,205,000 | 1.02% |
AlphaMark Advisors, LLC | 130,699 | $1,482,000 | 0.94% |
Cheyne Capital Management (UK) LLP | 172,353 | $1,955,000 | 0.70% |
Regal Investment Advisors LLC | 183,972 | $2,086,000 | 0.63% |
Tekla Capital Management LLC | 1,067,575 | $12,106,000 | 0.57% |
March Altus Capital Management LP | 103,729 | $1,176,000 | 0.47% |
CAPITAL MANAGEMENT ASSOCIATES /NY/ | 19,500 | $221,000 | 0.33% |